11.02.2017 Views

DESCRIPTIONS OF MEDICAL FUNGI

fungus3-book

fungus3-book

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

vi<br />

Descriptions of Medical Fungi<br />

PREFACE<br />

Frequently used molecular targets for species identification are outlined below:<br />

ITS<br />

D1/D2<br />

β-tubulin<br />

Molecular Target<br />

Internal transcribed spacer<br />

regions (ITS1-5.8S-ITS2)<br />

D1/D2 variable domains of<br />

the 28S rDNA gene<br />

Beta tubulin II<br />

Application<br />

Species level identification of wide<br />

range of fungi<br />

Species identification of many of the<br />

Mucorales<br />

Accurate species resolution of<br />

Aspergillus.<br />

Cal Calmodulin Species discrimination of Alternaria.<br />

EF-1α<br />

RPB1<br />

RPB2<br />

ACT<br />

GPDH<br />

Elongation factor alpha<br />

subunit<br />

RNA polymerase I subunit<br />

RNA polymerase II subunit<br />

Actin<br />

Glycerol-3-phosphate<br />

dehydrogenase<br />

Species complex identification of<br />

Fusarium.<br />

Species complex identification within<br />

genera of Fusarium, Penicillium and<br />

Talaromyces.<br />

Species discrimination of Aspergillus,<br />

Cladosporium, Coniochaeta, Verticillium,<br />

Verruconis.<br />

Species discrimination of Bipolaris,<br />

Curvularia, Verticillium.<br />

CHS Chitin synthase Species discrimination of Sporothrix<br />

Chi18-5 Chitinase 18-5 Species discrimination of Trichoderma<br />

Antifungal Susceptibility: For many species, antifungal susceptibility data has also<br />

been provided. This has been derived from both the literature and data from Australian<br />

clinical isolates generated by using the CLSI M27-A Standard for yeasts and the CLSI<br />

M38-A Standard for moulds. This composite data is provided as a guide only. In many<br />

cases the clinical relevance of in vitro antifungal susceptibility results remains difficult<br />

to interpret, and expert advice from a consulting microbiologist or infectious disease<br />

specialist may be required.<br />

CLSI M27-S4 clinical breakpoints are marked where available (green for susceptible,<br />

yellow for susceptible dose dependant or intermediate, red for resistant).<br />

Abbreviations: Amphotericin B (AmB), Fluconazole (FLU), Itraconazole (ITRA),<br />

Posaconazole (POSA), Voriconazole (VORI), Anidulafungin (ANID), Caspofungin<br />

(CAS), Micafungin (MICA), 5-Fluorocytosine (5FC), Terbinafine (TERB).<br />

Risk group (RG) recommendations are based on published data and on current<br />

definitions in accordance with the Australian/New Zealand Standard AS/NZS<br />

2243.3:2010. Safety in laboratories Part 3: Microbiological safety and containment.<br />

Note: International biosafety guidelines vary in their RG ratings of fungal species.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!